
Beyond the Hype: Turning Supplement Trends into Sustainable Strategies
Key Takeaways
- Amazon-driven unit growth is reinforcing durable demand, particularly for protein, condition-specific, and performance categories that are increasingly routinized across age cohorts.
- Younger cohorts are accelerating format innovation, with RTD beverages integrating nootropics and mushrooms and often outgrowing traditional supplements despite smaller absolute dollars.
At this SupplySide Connect presentation, panelists discussed how lasting supplement trends are being shaped at the intersection of consumer demand for performance and longevity, the convergence of food and supplements, and the need to balance innovation with disciplined legal and regulatory compliance.
In a presentation at this year’s SupplySide Connect New Jersey titled, The Supplement Trend Translator: From Smoke Signals to Clear Strategy, experts highlighted the top trends that regulatory and manufacturing implications brands need to understand to find success in this evolving and dynamic industry.
What Trends are Driving Supplement Innovation?
To start, Rahul Roy, Director, Vitamin and Specialty Retailers for the market research firm SPINS, provided a “state of the industry” overview showing that vitamins and supplements continue to experience strong, unit-driven growth, with Amazon as a major engine and evidence of real staying power rather than a short-lived spike. He highlighted three especially fast-growing areas: protein/meal supplements, condition-specific formulas, and performance nutrition (hydration, creatine, pre-/post-workout) that are becoming part of daily routines across age groups. Younger consumers, particularly Gen Z and millennials, are driving demand for convenient, lifestyle-friendly formats like gummies, powders, and liquids, which make supplementation feel less like a chore and more like a seamless part of the day. He showed how functional beverages (RTDs) are rapidly integrating ingredients such as nootropics and functional mushrooms, often outpacing traditional supplements in growth rate even though the absolute dollar size remains larger on the supplement side.
Protein remains an important ingredient category, explained Roy, having moved from the back panel to the front of pack and now spanning powders, bars, functional snacks, RTDs, protein shots, and even early experiments like carbonated protein drinks, enabling consumers to meet protein needs from breakfast through dinner. Another category driving innovation noted by Roy is longevity and healthy aging, which encompasses cellular wellness, recovery, muscle strength, and beauty-from-within benefits, shifting the question from “How do I get to old age?” to “How do I age well?” Within longevity, he pointed to emerging cellular-health ingredients—such as ubiquinol, selenium, resveratrol, NMN/NAD+ precursors, spermidine, and astaxanthin—that he believes are on their way to becoming household names as consumers look deeper than surface-level benefits. Additionally, Roy explained that the advent of AI, wearable technology, and biomarker/DNA testing creates a growing demand for clinically validated, practitioner-grade products.
What Are the Regulatory Implications for Supplement Innovation?
Theodora “Teddy” McCormick, a shareholder with Baker Donelson, noted many of the same trends highlighted by Roy, emphasizing once again that supplements are becoming a core part of daily health spend, especially for performance-minded consumers (e.g., Gen Z), and that the industry is shifting from commodity vitamins to branded, targeted wellness solutions such as mental health, women’s health, and active lifestyle products.
This industry shift complicated matters from a regulatory standpoint as the core regulatory constraint has not changed for supplement manufacturers: companies must avoid disease claims, staying in structure/function territory (e.g., “supports heart health” rather than “treats cardiovascular disease”), while navigating dual enforcement from FDA (safety/labeling) and FTC (marketing claims). Additionally, the rise of AI and data-rich personalization, companies will increasingly hold sensitive consumer health data (including elevated disease risk), which raises both claim-risk (implied disease treatment) and data privacy/security risk.
High-growth, high-risk areas for manufacturers to consider, include mental wellness (stress, mood, sleep), functional multi-benefit products, and sports/energy. McCormick explained how too many claims, weak substantiation, or gray-area stimulants and banned substances can trigger FDA/FTC action and follow-on class actions. She advised brands to focus on clear, narrow, well-substantiated benefit claims, avoid gray-area ingredients, and leverage third-party certifications (especially in sports) to build trust. Ultimately, she argued that companies that win will not necessarily be the early entrants, but the “disciplined translators” of hot trends into compliant, credible products—staying grounded firmly in structure/function territory, matching claims to evidence, simplifying messaging, investing early in regulatory and quality systems, and treating trust and transparency as core business assets.
Key Strategies for Manufacturers
Rounding out the panel, Abhijit Natu, Vice President of Sales and Marketing for Maypro, focused on how brands and ingredient suppliers can make strategic choices that turn broad trends into differentiated, successful products rather than trying to chase everything at once. He used the probiotics category as a case study, noting that the first probiotic product dates back to around World War I, but only much later did it become a mainstream, multi-benefit category—something nobody initially anticipated. In the early phases, capabilities were limited (refrigerated products, few strains, narrow benefit understanding), so the brands that won were those with clear focus—anchored on digestive health and simple potency stories rather than trying to be “everything for everybody.” Over time, as science evolved and more clinical studies were conducted, probiotics expanded into new benefit areas (like immune and brain health), but consistency of core messaging—especially around gut health and diversity—helped the category build a durable foundation.
Commenting on the common themes touched on by fellow panelists—longevity, mental health, cellular health, brain health, vision, healthy life span—Natu said that these concepts should be approached with a clear “entry point” and then thoughtfully scaled into adjacency benefits instead of launching with an unfocused laundry list. Scaling, in his view, can mean multiple things: more volume, more formats, and more health benefits, but all must remain logically connected back to the core benefit platform. Natu also highlighted the critical role of format and the food–supplement convergence, arguing that people want benefits “when, where, and how” they want them—hence the success of gummies, beverages, and functional foods that fit everyday habits better than traditional tablets or capsules. He concluded that winning strategies will deliver real, substantiated, multi-faceted benefits through versatile ingredients and formats that are scalable, regulatory-ready that appeal to consumers, so brands can cut through market noise and build lasting platforms rather than short-lived hits.
This article was created with assistance from AI. The content has been reviewed and edited by Sebastian Krawiec, Managing Editor, and by Erin McEvoy, Associate Editor. For more information on the extent and nature of AI usage, please contact us.





